Intervention Protocol

Dapagliflozin for type 2 diabetes mellitus

  1. Amit D Raval1,*,
  2. Ketan Chovatiya2,
  3. Ankit B Bhavsar3,
  4. Megha H Patel4

Editorial Group: Cochrane Metabolic and Endocrine Disorders Group

Published Online: 16 FEB 2011

DOI: 10.1002/14651858.CD009001

How to Cite

Raval AD, Chovatiya K, Bhavsar AB, Patel MH. Dapagliflozin for type 2 diabetes mellitus (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 2. Art. No.: CD009001. DOI: 10.1002/14651858.CD009001.

Author Information

  1. 1

    Institute of Pharmacy, Nirma University, Department of Pharmacology, Ahmedabad, Gujrat, India

  2. 2

    Shrimati Kaumudiniben Health Outcome Research Group (SKHORG), Surat, Gujarat, India

  3. 3

    Shrimati Kaumudiniben Health Outcome Research Group (SKHORG), Ahmedabad, Gujarat, India

  4. 4

    Shrimati Kaumudiniben Health Outcome Research Group (SKHORG), Dhrangadhra, Gujarat, India

*Amit D Raval, Department of Pharmacology, Institute of Pharmacy, Nirma University, Sarkhej-Gandhinagar Highway,, Ahmedabad, Gujrat, 382481, India. amitravalwaves@gmail.com. amit.raval@nirmauni.ac.in.

Publication History

  1. Publication Status: New
  2. Published Online: 16 FEB 2011

SEARCH